Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a Salivary miRNA Diagnostic Test for Autism Spectrum Disorder

NCT05418023 is registered in ClinicalTrials.gov with Quadrant Biosciences Inc. as lead sponsor.

NCT NCT05418023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05418023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a Salivary miRNA Diagnostic Test for Autism Spectrum Disorder
Lead sponsor
Quadrant Biosciences Inc.
Phase
Observational
Overall status
Unknown status
Start date
March 16, 2022
Completion date
July 31, 2023
Enrollment
6,604 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, developmental delay